EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
about
Customizing the genome as therapy for the β-hemoglobinopathiesHistone lysine methyltransferases as anti-cancer targets for drug discoveryChemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2Chemical probes targeting epigenetic proteins: Applications beyond oncology.New insights into sickle cell disease: mechanisms and investigational therapies.Alterations in nuclear structure promote lupus autoimmunity in a mouse model.Epigenetic Medicinal Chemistry.CRISPR-Cas9 technology and its application in haematological disorders.Clinically-oriented proteomic investigation of sickle cell disease: Opportunities and challenges.Use of genome-editing tools to treat sickle cell disease.Hemoglobin genetics: recent contributions of GWAS and gene editing.Gene Therapy for β-Hemoglobinopathies.The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.Fetal haemoglobin induction in sickle cell disease.Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies.Dual Inhibition of DNA and Histone Methyltransferases Increases Viral Mimicry in Ovarian Cancer CellsFetal Hemoglobin Induction by Epigenetic Drugs
P2860
Q26751061-5E7D28F5-F6ED-4B3B-9019-E9A8710F2CF8Q28076288-99132CC9-DEBA-401A-A626-97508F06828EQ28551340-C6922297-6A11-4BC5-AA87-95B252F3CED3Q33751386-B9840832-DFBB-4C86-A350-61D6F5311249Q37143296-E0C69518-9D7A-4341-97DF-DE147DDF2E3FQ37224632-3254D4E7-572A-4663-9D73-A8BC8E24E2C5Q38434114-6111B356-2842-4E56-A77C-9076241DFD82Q38822073-33C155A7-D7D8-4633-892F-46A0DC3B2B4DQ38837694-13304B6B-AA6B-43BA-8D5D-E497DDE50404Q38850483-8FA4FE67-7352-4ED8-944B-362E3A328185Q38875745-3C45B4F4-05E8-4D7F-BBE1-248EDDADA3E2Q39220089-00BE9270-B61A-49C3-A82D-2B2D5FC61B98Q42030522-FACAA2F7-C8ED-44E4-A154-A4798237527FQ45874514-36E42259-3241-4FCA-9AEA-FF6B6D7E40DAQ45875308-9945FB19-681F-4FB4-80E8-3A31442EEE13Q57461985-DA988AE8-3753-4F96-863C-1E17DD197D9FQ57753972-3068B5C4-C086-4DF3-AE7E-617D249183D1
P2860
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
@ast
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
@en
type
label
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
@ast
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
@en
prefLabel
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
@ast
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
@en
P2093
P2860
P1433
P1476
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression
@en
P2093
Aline Renneville
Benjamin L Ebert
Bradley E Bernstein
Daniel E Bauer
David M Dorfman
Edward B Holson
John M Krill-Burger
Marie McConkey
Stuart H Orkin
P2860
P304
P356
10.1182/BLOOD-2015-06-649087
P407
P577
2015-08-28T00:00:00Z